Atyr PHARMA (ATYR) Insider Trading & Ownership $3.80 +0.05 (+1.33%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$3.88 +0.08 (+2.00%) As of 05:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Atyr PHARMA (NASDAQ:ATYR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.70%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$187,369.48Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$8,138.34 Get ATYR Insider Trade Alerts Want to know when executives and insiders are buying or selling Atyr PHARMA stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ATYR Insider Buying and Selling by Quarter Atyr PHARMA Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/17/2025Jane A GrossDirectorBuy3,750$4.00$15,000.00 2/4/2025Jill Marie BroadfootCFOSell1,254$3.78$4,740.12 2/4/2025Nancy DenyesGeneral CounselSell899$3.78$3,398.22 7/24/2024Paul SchimmelDirectorBuy52,300$1.93$100,939.00 7/22/2024Paul SchimmelDirectorBuy41,052$1.74$71,430.48 (Data available from 1/1/2013 forward) ATYR Insider Trading Activity - Frequently Asked Questions Who is on Atyr PHARMA's Insider Roster? The list of insiders at Atyr PHARMA includes Jane A Gross, Jill Marie Broadfoot, Nancy Denyes, and Paul Schimmel. Learn more on insiders at ATYR. What percentage of Atyr PHARMA stock is owned by insiders? 3.70% of Atyr PHARMA stock is owned by insiders. Learn more on ATYR's insider holdings. Which Atyr PHARMA insiders have been buying company stock? The following insiders have purchased ATYR shares in the last 24 months: Jane A Gross ($15,000.00), and Paul Schimmel ($172,369.48). How much insider buying is happening at Atyr PHARMA? Insiders have purchased a total of 97,102 ATYR shares in the last 24 months for a total of $187,369.48 bought. Which Atyr PHARMA insiders have been selling company stock? The following insiders have sold ATYR shares in the last 24 months: Jill Marie Broadfoot ($4,740.12), and Nancy Denyes ($3,398.22). How much insider selling is happening at Atyr PHARMA? Insiders have sold a total of 2,153 Atyr PHARMA shares in the last 24 months for a total of $8,138.34 sold. Atyr PHARMA Key ExecutivesDr. Sanjay S. Shukla M.D. (Age 52)M.S., President, CEO & Director Compensation: $768.18kMs. Jill M. Broadfoot (Age 62)Chief Financial Officer Compensation: $544.75k1 recent tradesMs. Nancy E. Denyes Krueger (Age 56)General Counsel & Corporate Secretary Compensation: $518.2kXiang-Lei Yang Ph.D.FounderMs. Ashlee DunstonDirector of Investor Relations & Corporate CommunicationsMr. Peter VilligerVice President of Corporate DevelopmentMs. Danielle CampbellVP of Human ResourceDr. Leslie Nangle Ph.D.Vice President of ResearchDr. Ying J. Buechler Ph.D.Executive Director of Biologics Development & ManufacturingDr. David J. King Ph.D. (Age 65)Scientific Consultant Compensation: $327.31k More Insider Trading Tools from MarketBeat Related Companies Amphastar Pharmaceuticals Insider Selling Aurinia Pharmaceuticals Insider Selling Wave Life Sciences Insider Selling Gyre Therapeutics Insider Selling Phibro Animal Health Insider Selling Mineralys Therapeutics Insider Selling Collegium Pharmaceutical Insider Selling Syndax Pharmaceuticals Insider Selling Arcus Biosciences Insider Selling Enliven Therapeutics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Turbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market Cap This page (NASDAQ:ATYR) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atyr PHARMA INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Atyr PHARMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
